Do developing countries stand to benefit from the use of modern biotechnology?
Yes, but developing countries should remember that the institutional and economic environment within which modern biotechnology R&D is being conducted differs significantly from that of Green Revolution technologies. The latter was essentially the prerogative of public research institutions and philanthropic foundations. In contrast, the application of modern biotechnology to agriculture is a competitive, commercial endeavor in which powerful private sector interests compete. [72] Multinational companies in the seed, agricultural chemical, pharmaceutical and food-processing industries play a major role in biotechnology research. Also, as a result of mergers and acquisitions in the past years, the development of new biotechnology applications in agriculture has become increasingly concentrated in the hands of a few companies. The dominant companies that currently operate within the global markets are Monsanto, Syngenta and Pioneer Hi-Bred. The Food and Agriculture Organization has point
Related Questions
- What do developing countries whose primary exports are agricultural products stand to gain from services liberalization?
- Is the U.S. biotechnology industry pushing its products on developing countries through food aid programs?
- Can modern biotechnology solve the problems of developing countries in agriculture?
